Candel Therapeutics Inc (CADL)

9.11 +0.31 (+3.52%) USD  |  NASDAQ  |  Dec 26, 13:58
More

Candel Therapeutics Revenue Estimates for Next Fiscal Year

Revenue Estimates for Next Fiscal Year Chart

View Revenue Estimates for Next Fiscal Year for CADL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Next Fiscal Year Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Revenue Estimates for Next Fiscal Year Range, Past 5 Years

View Revenue Estimates for Next Fiscal Year Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Next Fiscal Year Benchmarks

View Revenue Estimates for Next Fiscal Year Benchmarks
Start Trial
Pfizer Inc Upgrade
AnaptysBio Inc Upgrade
Bristol-Myers Squibb Co Upgrade
Inovio Pharmaceuticals Inc Upgrade
NovaBay Pharmaceuticals Inc Upgrade

Revenue Estimates for Next Fiscal Year Related Metrics

Revenue Estimates for Next Quarter Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade